Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 139   

Articles published

VRX 197.84 -0.62 (-0.31%)
price chart
Valeant Pharmaceuticals International Inc faces high execution risk
The market clearly likes Valeant Pharmaceuticals International Inc.'s aggressive acquisition strategy, as the stock continues to consistently move higher.
Is Valeant Pharmaceuticals Intl Inc a $250 Stock?
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a long history of growing through acquisitions. In fact as I write this article it is rumoured to have secured financing to purchase Salix Pharmaceuticals.
Valuation Perspetives: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)  Stock Markets Daily
Share Price of Valeant Pharmaceuticals Intl Inc Rally 3.09%  Ashburn Daily
Valeant Pharmaceuticals International Inc. exploring Salix Pharmaceuticals Ltd ...
Valeant Pharmaceuticals International Inc. is exploring a takeover of Salix Pharmaceuticals Ltd., people with knowledge of the matter said, in the wake of the U.S.
Valeant Pharmaceuticals (VRX) Eyes Salix Pharmaceuticals As A Potential ...  Bidness ETC
Valeant Pharma In Talks To Buy Salix Pharma: Report  Nasdaq
With New Valeant Pharmaceuticals Intl Inc (VRX) Stake, Bill Ackman Maintains ...
In a new filing with the US Securities and Exchange Commission, activist investor Bill Ackman's Pershing Square disclosed a significant long position in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). According to the 13D filing, Pershing owns 19.47 ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Zero-based Budgeting For R&D  NYSE Post
Stocks in a bear Hug: Valeant Pharmaceuticals Intl (VRX), E I Du Pont De ...  Techsonian (press release)
Valeant Pharmaceuticals Intl Inc (VRX) Closes Follow-On Common Stock Issue ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) announced on Friday the close of its supplementary public offering (PO) in the US stock market of up to 7,286,432 common stock shares.
Valeant Pharmaceuticals Announces Offering Of $1.45 Billion Of Common Shares
LAVAL, Quebec, March 16, 2015 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it has filed with the U.S.
Valeant raises offer for Salix to $11.1 billion  CTV News
Deals of the Day: Macerich Rejects Simon's Bid, Pinterest Valued at $11 ...  Wall Street Journal (blog)
Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) today announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock ...
Valeant agrees to buy Salix in $14.5B deal  CTV News
Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares
LAVAL, Quebec, March 27, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today the closing of its previously announced registered offering of common shares in the United States (the "Offering").
Endo International plc (NASDAQ:ENDP) and Valeant Pharmaceuticals Intl Inc ...
Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) has been eying Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) vigilantly and has even made an offer worth $11.2 billion, which will be paid in cash and stock, for acquisition.
Valeant Announces HSR Clearance For Salix Acquisition  Canada NewsWire (press release)
Valeant Announces Pricing Of Private Offering Of Senior Notes  MarketWatch
Canaccord Genuity is Confident Valeant Pharmaceuticals Intl Inc Will Buy Salix ...
In a research report issued on March 16, Canaccord Genuity analyst Neil Maruoka maintained a Buy rating on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) with a price target of $230, after the pharmaceutical company increased its bid on Salix ...